IN2015DN02104A - - Google Patents

Info

Publication number: IN2015DN02104A
Authority: IN; India
Prior art keywords: pharmaceutically acceptable; patient; methods; need; disclosed compounds
Prior art date: 2012-09-13

Application number

Other languages

English (en)

Inventor

Giammaria Giuliani

Ralf Paus

Yuval Ramot

Sergio Baroni

Francesca Viti

Salvatore Bellinvia

Barbara Marzani

Original Assignee

Nogra Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-09-13

Filing date

2013-09-13

Publication date

2015-08-14

2013-09-13 Application filed by Nogra Pharma Ltd filed Critical Nogra Pharma Ltd

2015-08-14 Publication of IN2015DN02104A publication Critical patent/IN2015DN02104A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

IN2104DEN2015 2012-09-13 2013-09-13 IN2015DN02104A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261700623P	2012-09-13	2012-09-13
PCT/EP2013/069062 WO2014041140A1 (fr)	2012-09-13	2013-09-13	Procédés de traitement de troubles liés au système pileux

Publications (1)

Publication Number	Publication Date
IN2015DN02104A true IN2015DN02104A (fr)	2015-08-14

Family

ID=49170707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN2104DEN2015 IN2015DN02104A (fr)	2012-09-13	2013-09-13

Country Status (25)

Country	Link
US (2)	US20150250749A1 (fr)
EP (1)	EP2895160B1 (fr)
JP (1)	JP2015528479A (fr)
KR (1)	KR20150054934A (fr)
CN (1)	CN104837486A (fr)
AU (1)	AU2013314288B2 (fr)
BR (1)	BR112015005467A2 (fr)
CA (1)	CA2883823A1 (fr)
CY (1)	CY1120793T1 (fr)
DK (1)	DK2895160T3 (fr)
EA (1)	EA035986B1 (fr)
ES (1)	ES2675169T3 (fr)
HR (1)	HRP20181000T1 (fr)
HU (1)	HUE037903T2 (fr)
IL (1)	IL237449A0 (fr)
IN (1)	IN2015DN02104A (fr)
LT (1)	LT2895160T (fr)
MX (1)	MX356888B (fr)
NZ (1)	NZ705389A (fr)
PL (1)	PL2895160T3 (fr)
PT (1)	PT2895160T (fr)
SI (1)	SI2895160T1 (fr)
TR (1)	TR201809219T4 (fr)
UA (1)	UA116215C2 (fr)
WO (1)	WO2014041140A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
PT2396081T (pt)	2009-02-16	2017-07-11	Nogra Pharma Ltd	Compostos alquilamido e suas utilizações
EP2811993B1 (fr)	2012-02-09	2019-10-09	Nogra Pharma Limited	Méthodes de traitement de la fibrose
IN2014DN08157A (fr)	2012-04-18	2015-05-01	Nogra Pharma Ltd
SI3921299T1 (sl)	2019-02-08	2025-03-31	Nogra Pharma Limited	Postopek izdelave 3-(4'-aminofenil)-2-metoksipropionske kisline in njenih analogov in vmesnih proizvodov
WO2025132838A1 (fr) *	2023-12-20	2025-06-26	Nogra Pharma Limited	Formulations topiques pour l'acné

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT2396081T (pt) *	2009-02-16	2017-07-11	Nogra Pharma Ltd	Compostos alquilamido e suas utilizações
IN2014DN08157A (fr) *	2012-04-18	2015-05-01	Nogra Pharma Ltd

2013
- 2013-09-13 LT LTEP13762485.4T patent/LT2895160T/lt unknown
- 2013-09-13 EP EP13762485.4A patent/EP2895160B1/fr active Active
- 2013-09-13 HR HRP20181000TT patent/HRP20181000T1/hr unknown
- 2013-09-13 NZ NZ705389A patent/NZ705389A/en not_active IP Right Cessation
- 2013-09-13 PL PL13762485T patent/PL2895160T3/pl unknown
- 2013-09-13 CA CA2883823A patent/CA2883823A1/fr not_active Abandoned
- 2013-09-13 BR BR112015005467A patent/BR112015005467A2/pt active Search and Examination
- 2013-09-13 DK DK13762485.4T patent/DK2895160T3/en active
- 2013-09-13 WO PCT/EP2013/069062 patent/WO2014041140A1/fr not_active Ceased
- 2013-09-13 TR TR2018/09219T patent/TR201809219T4/tr unknown
- 2013-09-13 AU AU2013314288A patent/AU2013314288B2/en not_active Ceased
- 2013-09-13 US US14/428,164 patent/US20150250749A1/en not_active Abandoned
- 2013-09-13 UA UAA201503407A patent/UA116215C2/uk unknown
- 2013-09-13 CN CN201380047941.4A patent/CN104837486A/zh active Pending
- 2013-09-13 EA EA201590546A patent/EA035986B1/ru not_active IP Right Cessation
- 2013-09-13 SI SI201331087T patent/SI2895160T1/sl unknown
- 2013-09-13 JP JP2015531580A patent/JP2015528479A/ja active Pending
- 2013-09-13 MX MX2015003278A patent/MX356888B/es active IP Right Grant
- 2013-09-13 HU HUE13762485A patent/HUE037903T2/hu unknown
- 2013-09-13 IN IN2104DEN2015 patent/IN2015DN02104A/en unknown
- 2013-09-13 KR KR1020157009052A patent/KR20150054934A/ko not_active Withdrawn
- 2013-09-13 ES ES13762485.4T patent/ES2675169T3/es active Active
- 2013-09-13 PT PT137624854T patent/PT2895160T/pt unknown
2015
- 2015-02-26 IL IL237449A patent/IL237449A0/en unknown
2018
- 2018-06-28 CY CY20181100673T patent/CY1120793T1/el unknown
2020
- 2020-06-04 US US16/892,513 patent/US20210113505A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2883823A1 (fr)	2014-03-20
AU2013314288A1 (en)	2015-03-19
MX356888B (es)	2018-06-18
ES2675169T3 (es)	2018-07-09
CY1120793T1 (el)	2020-05-29
BR112015005467A2 (pt)	2017-07-04
UA116215C2 (uk)	2018-02-26
LT2895160T (lt)	2018-07-10
WO2014041140A1 (fr)	2014-03-20
EP2895160A1 (fr)	2015-07-22
US20150250749A1 (en)	2015-09-10
NZ705389A (en)	2018-08-31
PL2895160T3 (pl)	2018-09-28
US20210113505A1 (en)	2021-04-22
DK2895160T3 (en)	2018-06-25
SI2895160T1 (sl)	2018-09-28
JP2015528479A (ja)	2015-09-28
EA201590546A1 (ru)	2015-08-31
MX2015003278A (es)	2015-07-06
EA035986B1 (ru)	2020-09-09
CN104837486A (zh)	2015-08-12
HRP20181000T1 (hr)	2018-09-21
IL237449A0 (en)	2015-04-30
TR201809219T4 (tr)	2018-07-23
KR20150054934A (ko)	2015-05-20
PT2895160T (pt)	2018-06-29
EP2895160B1 (fr)	2018-05-30
AU2013314288B2 (en)	2018-07-05
HUE037903T2 (hu)	2018-09-28

Publication	Publication Date	Title
IN2015DN02104A (fr)	2015-08-14
CA2900335C (fr)	2021-10-26	Analogues synthetiques d'epipolythiodioxopiperazines et leurs utilisations
NZ631144A (en)	2016-12-23	Compositions and methods for transmucosal absorption
MX2020010535A (es)	2020-11-06	Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MY175521A (en)	2020-07-01	Melanin modification compositions and methods of use
MY171285A (en)	2019-10-07	Skin care compositions containing combinations of natural ingredients
BR112013026363A2 (pt)	2016-12-27	nanossuspensões de fármaco criodessecadas
IN2015DN01119A (fr)	2015-06-26
MX2015003021A (es)	2015-11-09	Derivados de acido glicirretinico y metodos de uso de los mismos.
BR112015001502A2 (pt)	2017-07-04	derivados de tipo azaindazol ou diazaindazol para tratamento de dor
MX345955B (es)	2017-02-28	Aditivo de composicion acondicionadora para proveer beneficios duraderos a los sustratos de queratina.
PH12015500746A1 (en)	2015-05-25	Benzamides
WO2013006335A3 (fr)	2013-04-25	Méthodes et compositions utiles pour traiter des types de peau fitzpatrick iv, v ou vi
PH12013500738A1 (en)	2016-08-05	Brimonidine gel compositions and methods of use
BR112012015984A2 (pt)	2018-05-29	composição para melhorar a função cerebral, e, polipeptídeo
WO2012130820A3 (fr)	2014-04-17	Esters d'isopentyle à utiliser dans des compositions cosmétiques, dermatologiques ou pharmaceutiques
MX2012007896A (es)	2012-08-01	Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
MX2014003449A (es)	2015-03-09	Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
MX2011013130A (es)	2012-02-13	Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
PH12013500679A1 (en)	2013-06-10	Topical gel composition
WO2011126940A3 (fr)	2012-09-07	Utilisations topiques de peptides de szeto-schiller
PH12019500345A1 (en)	2019-12-16	Conjugate of minoxidil and peptide
IN2015DN01329A (fr)	2015-07-03
WO2012092350A3 (fr)	2012-09-27	Peptides de szeto-schiller pour utilisation topique
MY166057A (en)	2018-05-22	Carbocyclic nucleosides and their pharmaceutical use and compositions